Product Overview of RapidAI
RapidAI is a cutting-edge, AI-powered platform designed to revolutionize the diagnosis, treatment, and management of cerebrovascular diseases, particularly stroke and cerebral aneurysms. Here’s a comprehensive overview of what the product does and its key features and functionality.
Purpose and Scope
RapidAI is tailored to assist clinicians in the rapid and accurate diagnosis and treatment of stroke and other cerebrovascular conditions. The platform integrates operational, clinical, and imaging performance data to provide deep insights into patient care, enhancing decision-making and improving patient outcomes.
Key Features and Functionality
Stroke Detection and Management
- Rapid ICH: Quickly triages non-contrast computed tomography (CT) scans to identify suspected intracranial hemorrhages (ICH).
- Rapid ASPECTS: Automatically identifies regions of the brain and generates a score to help physicians assess patient eligibility for thrombectomy.
- Rapid LVO: Identifies large vessel occlusions (LVOs) to streamline triage and faster transfer decisions for patients.
- Rapid CTP: Provides quantified and color-coded CT perfusion maps to assess salvageable brain tissue, aiding in acute stroke therapy decisions.
Imaging Analysis
- Rapid CTA: Automatically identifies reduced vessel density and regions of asymmetry in the brain using CT angiography scans.
- Rapid MRI: Analyzes magnetic resonance imaging (MRI) brain images, delivering advanced MR diffusion and perfusion image analysis to identify brain regions with reduced apparent diffusion coefficient (ADC) and critically hypoperfused tissue.
Aneurysm Management
- SurgicalPreview: Offers comprehensive cerebral aneurysm management, automating the workflow from initial assessment to growth monitoring and treatment planning. It converts 2D images to 3D vasculature models, highlights potential aneurysms, and calculates clinically relevant measurements.
Workflow and Communication
- Rapid Mobile and Web Apps: Enables streamlined communication and workflow across treatment teams and hospitals, facilitating faster treatment and decision-making.
- RapidAI Insights: Provides a comprehensive suite of reports combining operational, clinical, and imaging performance data to deliver deep insights on patient care and help hospitals make informed business decisions.
Additional Capabilities
- Automated Analysis: RapidAI automates the process of finding, tracking, and proactively treating aneurysms, and it provides high-resolution measurement tools to help clinicians precisely measure and visualize morphological changes.
- Regulatory Compliance: The platform is FDA-approved and licensed for sale in various countries, including Canada as a Class III medical device.
Benefits
- Time Efficiency: Reduces crucial time intervals in stroke care by facilitating faster triage, decision-making, and treatment initiation.
- Improved Outcomes: Enhances patient outcomes by enabling clinicians to make faster and more accurate diagnostic and treatment decisions.
- Global Reach: With a presence in over 1,600 hospitals across more than 60 countries, RapidAI is a global leader in advanced cerebrovascular imaging and workflow.
In summary, RapidAI is a robust and clinically validated platform that leverages artificial intelligence to streamline and enhance the diagnosis, treatment, and management of stroke and cerebral aneurysms, ultimately improving patient care and outcomes.